Surgery Partners Elevated to Hold Status by StockNews.com Amidst Analysts' Perspectives

Investment analysts at StockNews.com recently revised their outlook on Surgery Partners, Inc. SGRY, shifting the company's stock rating from 'sell' to 'hold'. This update reflects the firm's latest assessment of the healthcare service provider's market positioning, as stated in a report published on Friday.

Analyst Ratings and Price Targets

While StockNews.com has taken a more conservative stance, other research analysts continue to actively evaluate SGRY. Barclays, for instance, adjusted their price target on Surgery Partners from $56.00 to $51.00 but maintained an 'overweight' rating. Benchmark echoed a confident sentiment with a reaffirmed 'buy' rating and a price target set at $50.00. However, TheStreet offered a less favorable view, downgrading SGRY from a 'c-' to a 'd+' rating. In contrast, Cantor Fitzgerald stood their ground with an 'overweight' rating and a $43.00 price goal. Presently, the collective opinion from these analysts leans towards a 'Moderate Buy' consensus with an average price target around $44.09.

Company's Market Performance

The share value for Surgery Partners began trading at $26.18 on the announcement day. The company has experienced a trading spectrum reaching from a low of $22.05 to a peak value of $45.79 over the past year. SGRY's financial health shows a current ratio of 1.75, a prompt liquidity ratio of 1.61, and a debt-to-equity figure at 0.88. The share price currently hovers above the 50-day and 200-day moving averages, indicative of $27.80 and $34.65, respectively. The company's market capital stands at $3.31 billion, with a PE ratio signaling at -81.81 and a beta value of 2.78, suggesting a higher market volatility.

Insider Activity and Institutional Investors

Insider transactions included a notable sale by Harrison R. Bane, who liquidated 3,835 shares at an average price of $35.98, totaling to $137,983.30. Following the sale, Bane remains in possession of 46,709 company shares, valued approximately at $1,680,589.82. Company insiders collectively hold 2.60% of Surgery Partners' equity. A dive into the institutional investors' moves shows Chase Investment Counsel Corp entering a new position with a $2,338,000 investment in SGRY, while Bank of New York Mellon Corporation BK augmented their stake by 2.0%, aligning their holding to 236,244 shares valued close to $8,143,000 after an additional acquisition of 4,739 shares. Other institutional activities include FORA Capital LLC, Premier Fund Managers Ltd, and Walled Lake Planning & Wealth Management LLC making significant new investments in the company during the reported periods.

About Surgery Partners

Surgery Partners, with its headquarters situated in Brentwood, Tennessee, operates through its subsidiaries a comprehensive network of surgical facilities and supportive services across the United States. The company, divided into Surgical Facility Services and Ancillary Services segments, specializes in providing non-emergency surgical procedures in various medical specialties such as orthopedics, pain management, ophthalmology, gastroenterology, and general surgery.

SurgeryPartners, StockUpgrade, Investment